Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$9.02 - $10.29 $18 - $20
2 Added 0.9%
223 $2,000
Q1 2023

Apr 18, 2023

BUY
$9.2 - $12.26 $18 - $24
2 Added 0.91%
221 $2,000
Q4 2022

Jan 17, 2023

BUY
$8.72 - $11.56 $17 - $23
2 Added 0.92%
219 $0
Q3 2022

Oct 12, 2022

BUY
$8.48 - $11.13 $16 - $22
2 Added 0.93%
217 $2,000
Q2 2022

Jul 19, 2022

SELL
$9.95 - $12.27 $119 - $147
-12 Reduced 5.29%
215 $2,000
Q1 2022

May 10, 2022

SELL
$9.81 - $15.4 $313 - $492
-32 Reduced 12.36%
227 $2,000
Q4 2021

Feb 09, 2022

BUY
$12.09 - $14.68 $338 - $411
28 Added 12.12%
259 $4,000
Q2 2021

Aug 05, 2021

BUY
$12.97 - $16.15 $505 - $629
39 Added 20.31%
231 $3,000
Q1 2021

May 14, 2021

SELL
$13.59 - $18.54 $1,168 - $1,594
-86 Reduced 30.94%
192 $3,000
Q4 2020

Feb 05, 2021

BUY
$14.3 - $18.74 $3,975 - $5,209
278 New
278 $5,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Horan Securities, Inc. Portfolio

Follow Horan Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Securities, Inc. with notifications on news.